
Louise Chen
Stock Analyst at Scotiabank
(4.68)
# 839
Out of 5,152 analysts
1228
Total ratings
55.5%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Louise Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Reiterated: Buy | $200 | $168.98 | +18.36% | 20 | Nov 10, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $180 | $137.78 | +30.64% | 78 | Nov 10, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $305 | $272.70 | +11.84% | 76 | Nov 9, 2026 | |
| AMGN Amgen | Reiterated: Buy | $500 → $530 | $443.89 | +19.40% | 16 | Nov 4, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 15,297 | ILA 13,920 | +9.89% | 3 | Nov 4, 2026 | |
| PFE Pfizer | Reiterated: Buy | $33 → $35 | $28.06 | +24.73% | 106 | Nov 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $558 → $660 | $536.45 | +23.03% | 14 | Nov 3, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 | $59.56 | +0.74% | 19 | Oct 30, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,300 → $1,605 | $1,382.75 | +16.07% | 81 | Oct 30, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $320 | $286.01 | +11.88% | 28 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $770 | $945.53 | -18.56% | 16 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40.00 | $41.17 | -2.84% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $18.40 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $14.53 | n/a | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $27.81 | n/a | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.12 | n/a | 13 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.50 | n/a | 62 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $15.87 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 | $60.23 | n/a | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $146.58 | n/a | 7 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.7801 | n/a | 7 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.11 | n/a | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $22.11 | n/a | 10 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $41.37 | n/a | 4 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.69 | n/a | 4 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $39.43 | n/a | 7 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $58.52 | n/a | 9 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.74 | n/a | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.81 | n/a | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4403 | n/a | 4 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7841 | n/a | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.82 | n/a | 7 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.874 | n/a | 24 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.28 | n/a | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.73 | n/a | 14 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.07 | n/a | 47 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $45 | $33.17 | n/a | 3 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $34 | $11.64 | n/a | 6 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.81 | n/a | 26 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 73.00 | CHF 71.50 | n/a | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $27.61 | n/a | 11 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $250 | $0.0002 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $13.99 | n/a | 5 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $11.26 | n/a | 105 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.9031 | n/a | 11 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $9 | $14.35 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.70 | n/a | 5 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $85.57 | n/a | 48 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.6652 | n/a | 1 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $18 | $0.0001 | n/a | 12 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $5 | $0.3532 | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €97.32 | €149.50 | n/a | 1 | Apr 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $20.28 | n/a | 24 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $70 | $16.94 | n/a | 52 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45.78 → $51.51 | $12.52 | n/a | 71 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €12.00 | €0.28 | n/a | 1 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33 | $0.6711 | n/a | 1 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $21.88 | n/a | 24 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.69 | n/a | 11 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $50 | $0.273 | n/a | 23 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.80 | n/a | 1 | Sep 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.0001 | n/a | 12 | Jul 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.98 | n/a | 5 | Jun 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $247.77 | n/a | 10 | Apr 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $71.47 | n/a | 6 | Apr 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $37.75 | n/a | 1 | Sep 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $45 | $35.57 | n/a | 2 | Jun 24, 2015 |
Gilead Sciences
Nov 10, 2026
Reiterated: Buy
Price Target: $200
Current: $168.98
Upside: +18.36%
Merck & Co.
Nov 10, 2026
Reiterated: Buy
Price Target: $180
Current: $137.78
Upside: +30.64%
Johnson & Johnson
Nov 9, 2026
Reiterated: Buy
Price Target: $305
Current: $272.70
Upside: +11.84%
Amgen
Nov 4, 2026
Reiterated: Buy
Price Target: $500 → $530
Current: $443.89
Upside: +19.40%
Teva Pharmaceutical Industries Limited
Nov 4, 2026
Reiterated: Buy
Price Target: ILA 15,297
Current: ILA 13,920
Upside: +9.89%
Pfizer
Nov 4, 2026
Reiterated: Buy
Price Target: $33 → $35
Current: $28.06
Upside: +24.73%
Vertex Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $558 → $660
Current: $536.45
Upside: +23.03%
Bristol-Myers Squibb Company
Oct 30, 2026
Reiterated: Hold
Price Target: $60
Current: $59.56
Upside: +0.74%
Eli Lilly and Company
Oct 30, 2026
Reiterated: Buy
Price Target: $1,300 → $1,605
Current: $1,382.75
Upside: +16.07%
AbbVie
Oct 29, 2026
Reiterated: Buy
Price Target: $320
Current: $286.01
Upside: +11.88%
Oct 14, 2026
Reiterated: Hold
Price Target: $770
Current: $945.53
Upside: -18.56%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40.00
Current: $41.17
Upside: -2.84%
Aug 7, 2025
Reiterated: Buy
Price Target: $55
Current: $18.40
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $80
Current: $14.53
Upside: n/a
Aug 6, 2025
Reiterated: Buy
Price Target: $17
Current: $27.81
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $15
Current: $3.12
Upside: n/a
Jul 30, 2025
Reiterated: Buy
Price Target: $9
Current: $3.50
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: $50
Current: $15.87
Upside: n/a
Jul 29, 2025
Reiterated: Hold
Price Target: $55
Current: $60.23
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: $50
Current: $146.58
Upside: n/a
Jul 10, 2025
Reiterated: Buy
Price Target: $15
Current: $0.7801
Upside: n/a
Jul 9, 2025
Reiterated: Buy
Price Target: $12
Current: $1.11
Upside: n/a
Jul 2, 2025
Reiterated: Buy
Price Target: $55
Current: $22.11
Upside: n/a
Jun 27, 2025
Reiterated: Hold
Price Target: $14
Current: $41.37
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: $30
Current: $3.69
Upside: n/a
Jan 28, 2025
Rated: Hold
Price Target: n/a
Current: $39.43
Upside: n/a
Jan 28, 2025
Rated: Hold
Price Target: n/a
Current: $58.52
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $8.74
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $1.81
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $0.4403
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $0.7841
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $2.82
Upside: n/a
Jan 3, 2025
Rated: Hold
Price Target: n/a
Current: $0.874
Upside: n/a
Jun 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $9.28
Upside: n/a
May 30, 2024
Reiterated: Buy
Price Target: n/a
Current: $38.73
Upside: n/a
Jan 16, 2024
Reiterated: Buy
Price Target: n/a
Current: $7.07
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $30 → $45
Current: $33.17
Upside: n/a
Aug 30, 2023
Reiterated: Buy
Price Target: $46 → $34
Current: $11.64
Upside: n/a
Aug 16, 2023
Reiterated: Hold
Price Target: $5
Current: $1.81
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: CHF 73.00
Current: CHF 71.50
Upside: n/a
Aug 8, 2023
Reiterated: Buy
Price Target: $50
Current: $27.61
Upside: n/a
Aug 8, 2023
Initiated Coverage: Buy
Price Target: $50 → $250
Current: $0.0002
Upside: n/a
Jul 24, 2023
Rated: Buy
Price Target: $50
Current: $13.99
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $5
Current: $11.26
Upside: n/a
Jul 6, 2023
Reiterated: Buy
Price Target: $25
Current: $0.9031
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $180 → $9
Current: $14.35
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 13, 2023
Rated: Hold
Price Target: n/a
Current: $6.70
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: $250
Current: $85.57
Upside: n/a
Jun 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.6652
Upside: n/a
Dec 21, 2021
Reiterated: Buy
Price Target: $25 → $18
Current: $0.0001
Upside: n/a
Sep 20, 2021
Reiterated: Buy
Price Target: $15 → $5
Current: $0.3532
Upside: n/a
Apr 29, 2020
Reiterated: Buy
Price Target: €97.32
Current: €149.50
Upside: n/a
Mar 25, 2020
Reiterated: Hold
Price Target: $22
Current: $20.28
Upside: n/a
Jan 21, 2020
Reiterated: Buy
Price Target: $60 → $70
Current: $16.94
Upside: n/a
Jan 9, 2020
Reiterated: Buy
Price Target: $45.78 → $51.51
Current: $12.52
Upside: n/a
Dec 16, 2019
Initiated Coverage: Buy
Price Target: €12.00
Current: €0.28
Upside: n/a
Oct 22, 2019
Initiated Coverage: Buy
Price Target: $33
Current: $0.6711
Upside: n/a
May 9, 2019
Reiterated: Buy
Price Target: $35
Current: $21.88
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $20
Current: $1.69
Upside: n/a
Sep 27, 2018
Rated: Buy
Price Target: $30 → $50
Current: $0.273
Upside: n/a
Sep 25, 2018
Reiterated: Buy
Price Target: n/a
Current: $0.80
Upside: n/a
Jul 24, 2018
Rated: Buy
Price Target: $16
Current: $0.0001
Upside: n/a
Jun 28, 2018
Reiterated: Buy
Price Target: $26
Current: $2.98
Upside: n/a
Apr 6, 2017
Reiterated: Buy
Price Target: n/a
Current: $247.77
Upside: n/a
Apr 5, 2017
Reiterated: Buy
Price Target: $80
Current: $71.47
Upside: n/a
Sep 26, 2016
Initiated Coverage: Buy
Price Target: $20
Current: $37.75
Upside: n/a
Jun 24, 2015
Reiterated: Buy
Price Target: $40 → $45
Current: $35.57
Upside: n/a